- Home
- GTLB vs ROIV Comparison
GTLB vs ROIV Comparison
Compare GTLB & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTLB
- ROIV
- Stock Information
- Founded
- GTLB 2011
- ROIV 2014
- Country
- GTLB United States
- ROIV United Kingdom
- Employees
- GTLB N/A
- ROIV N/A
- Industry
- GTLB EDP Services
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- GTLB Technology
- ROIV Health Care
- Exchange
- GTLB Nasdaq
- ROIV Nasdaq
- Market Cap
- GTLB 7.0B
- ROIV 8.4B
- IPO Year
- GTLB 2021
- ROIV N/A
- Fundamental
- Price
- GTLB $49.16
- ROIV $10.64
- Analyst Decision
- GTLB Strong Buy
- ROIV Buy
- Analyst Count
- GTLB 23
- ROIV 4
- Target Price
- GTLB $71.22
- ROIV $17.50
- AVG Volume (30 Days)
- GTLB 2.4M
- ROIV 6.4M
- Earning Date
- GTLB 06-02-2025
- ROIV 05-29-2025
- Dividend Yield
- GTLB N/A
- ROIV N/A
- EPS Growth
- GTLB N/A
- ROIV N/A
- EPS
- GTLB N/A
- ROIV N/A
- Revenue
- GTLB $759,249,000.00
- ROIV $122,585,000.00
- Revenue This Year
- GTLB $26.41
- ROIV N/A
- Revenue Next Year
- GTLB $22.21
- ROIV N/A
- P/E Ratio
- GTLB N/A
- ROIV N/A
- Revenue Growth
- GTLB 30.93
- ROIV 140.04
- 52 Week Low
- GTLB $37.90
- ROIV $8.73
- 52 Week High
- GTLB $74.18
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- GTLB 56.90
- ROIV 47.30
- Support Level
- GTLB $44.53
- ROIV $11.02
- Resistance Level
- GTLB $47.41
- ROIV $11.77
- Average True Range (ATR)
- GTLB 1.81
- ROIV 0.33
- MACD
- GTLB 0.84
- ROIV -0.02
- Stochastic Oscillator
- GTLB 87.98
- ROIV 28.93
About GTLB GitLab Inc.
GitLab Inc operates on an all-remote model. GitLab, a complete DevSecOps platform delivered as a single application. It operates in two competitive landscapes: DevOps point solutions and DevOps platforms. In terms of point solutions that are stitched together, GitLab's offering is substantially different in that it is one platform, one codebase, one interface, and a unified data model that spans the entire DevSecOps lifecycle. DevOps platforms, the principal competitor is Microsoft Corporation following their acquisition of GitHub. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. It is located in the United States, Europe, and Asia Pacific. It focused on accelerating innovation and broadening the distribution of its platform to companies across the world.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.